You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 13, Issue 10

October 2020 - 64 articles

Cover Story: This paper describes how novel anti-EGFR antibody-drug conjugates (ABT-414, ABBV-221, and ABBV-321) that selectively target a tumor-selective (mAb806) epitope were evaluated for the treatment of malignant mesothelioma. EGFR and mAb806 epitope expression in malignant mesothelioma cell lines was confirmed using in vitro assays. Biodistribution and imaging studies demonstrated specific targeting of malignant mesothelioma tumors using an 89Zr-labeled immunoconjugate-ch806. In vivo therapy studies were conducted in malignant mesothelioma xenograft and PDX tumor models. ABT-414, ABBV-221, and ABBV-322 resulted in significant growth inhibition in tumors with high EGFR and mAb806 epitope expression. In contrast, in an EGFR expressing PDX model that was negative for the mAb806 epitope, no growth inhibition was observed. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (64)

  • Feature Paper
  • Article
  • Open Access
32 Citations
5,906 Views
11 Pages

Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study

  • Benjamin Rossi,
  • Lee S. Nguyen,
  • Philippe Zimmermann,
  • Faiza Boucenna,
  • Louis Dubret,
  • Louise Baucher,
  • Helene Guillot,
  • Marie-Anne Bouldouyre,
  • Yves Allenbach and
  • Joe-Elie Salem
  • + 3 authors

17 October 2020

Tocilizumab, an anti-interleukin-6 receptor, administrated during the right timeframe may be beneficial against coronavirus-disease-2019 (COVID-19) pneumonia. All patients admitted for severe COVID-19 pneumonia (SpO2 ≤ 96% despite O2-support ≥...

  • Communication
  • Open Access
15 Citations
4,584 Views
20 Pages

Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells

  • Maritza P. Garrido,
  • Renato Salvatierra,
  • Manuel Valenzuela-Valderrama,
  • Christopher Vallejos,
  • Nicole Bruneau,
  • Andrea Hernández,
  • Margarita Vega,
  • Alberto Selman,
  • Andrew F. G. Quest and
  • Carmen Romero

16 October 2020

Epithelial ovarian cancer (EOC) is a lethal gynaecological neoplasm characterized by rapid growth and angiogenesis. Nerve growth factor (NGF) and its high affinity receptor tropomyosin receptor kinase A (TRKA) contribute to EOC progression by increas...

  • Article
  • Open Access
16 Citations
4,690 Views
10 Pages

Novel Photosensitizer β-Mannose-Conjugated Chlorin e6 as a Potent Anticancer Agent for Human Glioblastoma U251 Cells

  • Yo Shinoda,
  • Kohei Kujirai,
  • Kohei Aoki,
  • Mai Morita,
  • Masato Masuda,
  • Lihao Zhang,
  • Zhou Kaixin,
  • Akihiro Nomoto,
  • Tsutomu Takahashi and
  • Yayoi Tsuneoka
  • + 7 authors

16 October 2020

A photosensitizer is a molecular drug for photodynamic diagnosis and photodynamic therapy (PDT) against cancer. Many studies have developed photosensitizers, but improvements in their cost, efficacy, and side effects are needed for better PDT of pati...

  • Article
  • Open Access
4 Citations
4,293 Views
15 Pages

Development of a Multivariate Predictive Dissolution Model for Tablets Coated with Cellulose Ester Blends

  • Eman M. Mohamed,
  • Tahir Khuroo,
  • Hamideh Afrooz,
  • Sathish Dharani,
  • Khaldia Sediri,
  • Phillip Cook,
  • Rajendran Arunagiri,
  • Mansoor A. Khan and
  • Ziyaur Rahman

15 October 2020

The focus of the present investigation was to develop a predictive dissolution model for tablets coated with blends of cellulose acetate butyrate (CAB) 171-15 and cellulose acetate phthalate (C-A-P) using the design of experiment and chemometric appr...

  • Article
  • Open Access
16 Citations
5,003 Views
17 Pages

New Class of Efficient T2 Magnetic Resonance Imaging Contrast Agent: Carbon-Coated Paramagnetic Dysprosium Oxide Nanoparticles

  • Huan Yue,
  • Ji Ae Park,
  • Son Long Ho,
  • Mohammad Yaseen Ahmad,
  • Hyunsil Cha,
  • Shuwen Liu,
  • Tirusew Tegafaw,
  • Shanti Marasini,
  • Adibehalsadat Ghazanfari and
  • Soyeon Kim
  • + 3 authors

15 October 2020

Nanoparticles are considered potential candidates for a new class of magnetic resonance imaging (MRI) contrast agents. Negative MRI contrast agents require high magnetic moments. However, if nanoparticles can exclusively induce transverse water proto...

  • Article
  • Open Access
29 Citations
4,885 Views
20 Pages

Brain-Targeted Delivery of Pre-miR-29b Using Lactoferrin-Stearic Acid-Modified-Chitosan/Polyethyleneimine Polyplexes

  • Patrícia Pereira,
  • Maria Barreira,
  • Carla Cruz,
  • Joana Tomás,
  • Ângelo Luís,
  • Augusto Q. Pedro,
  • João A. Queiroz and
  • Fani Sousa

15 October 2020

The efficacy of brain therapeutics is largely hampered by the presence of the blood–brain barrier (BBB), mainly due to the failure of most (bio) pharmaceuticals to cross it. Accordingly, this study aims to develop nanocarriers for targeted deli...

  • Review
  • Open Access
68 Citations
9,728 Views
17 Pages

Medicinal Plants to Strengthen Immunity during a Pandemic

  • Olga Babich,
  • Stanislav Sukhikh,
  • Alexander Prosekov,
  • Lyudmila Asyakina and
  • Svetlana Ivanova

15 October 2020

The development of new effective anti-coronavirus drugs and therapies is important, but it requires significant human, financial and, most importantly, time expenditures. The current pandemic is neither the first nor the last. Humanity has already ac...

  • Review
  • Open Access
67 Citations
10,751 Views
29 Pages

14 October 2020

Diabetes mellitus is a chronic endocrine disease, affecting more than 400 million people around the world. Patients with poorly controlled blood glucose levels are liable to suffer from life-threatening complications, such as cardiovascular, neuropat...

  • Article
  • Open Access
29 Citations
4,349 Views
21 Pages

14 October 2020

Five novel peptides (LPLF, WLQL, LPSW, VPGLAL, and LVGLPL) bearing dipeptidyl peptidase IV (DPP-IV) inhibitory activities were identified from the gastrointestinal enzymatic hydrolysate of soft-shelled turtle yolk (SSTY) proteins. Peptides were isola...

  • Feature Paper
  • Review
  • Open Access
28 Citations
33,949 Views
51 Pages

Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse Effects

  • Pietro Brunetti,
  • Alfredo Fabrizio Lo Faro,
  • Anastasio Tini,
  • Francesco Paolo Busardò and
  • Jeremy Carlier

14 October 2020

Sexual enhancers increase sexual potency, sexual pleasure, or libido. Substances increasing libido alter the concentrations of specific neurotransmitters or sex hormones in the central nervous system. Interestingly, the same pathways are involved in...

of 7

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247